ATE269063T1 - Formulierungen zur transdermalen verabreichung von fenoldopam - Google Patents

Formulierungen zur transdermalen verabreichung von fenoldopam

Info

Publication number
ATE269063T1
ATE269063T1 AT99935613T AT99935613T ATE269063T1 AT E269063 T1 ATE269063 T1 AT E269063T1 AT 99935613 T AT99935613 T AT 99935613T AT 99935613 T AT99935613 T AT 99935613T AT E269063 T1 ATE269063 T1 AT E269063T1
Authority
AT
Austria
Prior art keywords
fenoldopam
transdermal administration
formulations
membrane
composition
Prior art date
Application number
AT99935613T
Other languages
English (en)
Inventor
Osdol William W Van
Nieves M Crisologo
Su Il Yum
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE269063T1 publication Critical patent/ATE269063T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
AT99935613T 1998-07-24 1999-07-16 Formulierungen zur transdermalen verabreichung von fenoldopam ATE269063T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9405998P 1998-07-24 1998-07-24
PCT/US1999/016083 WO2000004886A1 (en) 1998-07-24 1999-07-16 Formulations for the transdermal administration of fenoldopam

Publications (1)

Publication Number Publication Date
ATE269063T1 true ATE269063T1 (de) 2004-07-15

Family

ID=22242614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99935613T ATE269063T1 (de) 1998-07-24 1999-07-16 Formulierungen zur transdermalen verabreichung von fenoldopam

Country Status (8)

Country Link
EP (1) EP1100476B1 (de)
JP (1) JP2002521324A (de)
AT (1) ATE269063T1 (de)
AU (1) AU5105699A (de)
DE (1) DE69918124T2 (de)
ES (1) ES2219037T3 (de)
PT (1) PT1100476E (de)
WO (1) WO2000004886A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3035308A1 (en) * 2016-08-31 2018-03-08 Taro Pharmaceutical Industries, Ltd. Fenoldopam topical formulations for treating skin disorders
US11446237B2 (en) 2019-03-08 2022-09-20 Taro Pharmaceutical Industries Ltd. Stable topical compositions of fenoldopam

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197297A (en) * 1976-11-17 1980-04-08 Smithkline Corporation 6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB9009390D0 (en) * 1990-04-26 1990-06-20 Smith Kline French Lab Pharmaceutical compositions
EP1021204B1 (de) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen

Also Published As

Publication number Publication date
AU5105699A (en) 2000-02-14
EP1100476A1 (de) 2001-05-23
DE69918124D1 (de) 2004-07-22
ES2219037T3 (es) 2004-11-16
HK1036594A1 (en) 2002-01-11
JP2002521324A (ja) 2002-07-16
PT1100476E (pt) 2004-10-29
EP1100476B1 (de) 2004-06-16
DE69918124T2 (de) 2004-10-21
WO2000004886A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
ATE361073T1 (de) Neue formulierungen zur transdermalen verabreichung von pergolid
ATE277620T1 (de) Neue formulierungen zur transdermale verabreichung von fluoxetinacetat und fluoxetinmaleat
MX9709162A (es) Composiciones mejoradas de la permeacion en la piel que usan lactilatos de acilo.
DK0934078T3 (da) Permeabilitetsfremmere til transdermal administrering af aktivstoffer, anordninger og fremgangsmåde til fremstilling deraf
PT740650E (pt) Co-farmacos como um metodo de administracao controlada de farmacos
ATE347879T1 (de) Transdermale pharmazeutische zusammensetzung zur wirkstoffverabreichung
WO2000048445A3 (de) Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit
ATE269063T1 (de) Formulierungen zur transdermalen verabreichung von fenoldopam
ATE228843T1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
JO2492B1 (en) A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
DE50010973D1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
DE60112584D1 (de) Verfahren zur Herstellung einer flüssigen Dosierungseinheit und Kit
SE0203817D0 (sv) New composition
DK1216036T3 (da) Transdermal administration af N-(2,5-disubstitueret phenyl)-N'-(3-substitueret phenyl)-N'-methylguanidin
WO2001035927A3 (en) Topical application of muscarinic analgesic drugs such as neostigmine
RU2002123991A (ru) Способ лечения красного плоского лишая

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1100476

Country of ref document: EP

REN Ceased due to non-payment of the annual fee